drugset / Trial / NCT01958775

Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2

NCT01958775

Phase 3 Completed 12 enrolled University Health Network, Toronto
RandomizedCrossoverSingle-blindBasic science

Summary

1. To assess whether Glucagon like peptide 2 (GLP-2) affects lipoprotein production (study A) 2. To assess whether GLP-2 affects the release of preformed chylomicrons (study B)

Timeline

Start
2012-03
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject GLUCAGON-LIKE PEPTIDE II Peptide 1500 ug Subcutaneous

Indications